0 224

Cited 10 times in

Urologic cancers in Korea

Authors
 Kyo Chul Koo  ;  Kwang Suk Lee  ;  Byung Ha Chung 
Citation
 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, Vol.45(9) : 805-811, 2015 
Journal Title
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
ISSN
 0368-2811 
Issue Date
2015
MeSH
Humans ; Kidney Neoplasms/epidemiology* ; Kidney Neoplasms/mortality ; Kidney Neoplasms/pathology ; Male ; Neoplasm Metastasis ; Prevalence ; Prostatic Neoplasms/epidemiology* ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Republic of Korea/epidemiology ; Survival Rate ; Urinary Bladder Neoplasms/epidemiology* ; Urinary Bladder Neoplasms/mortality ; Urinary Bladder Neoplasms/pathology
Keywords
bladder cancer ; kidney cancer ; prostate cancer
Abstract
The incidence and prevalence of prostate and kidney cancers have been increasing in Korea during the last decade, and a marked improvement in survival rates has been noted. With a substantial proportion of the cancers diagnosed at an earlier stage of the disease, the landscape of urologic cancer treatment in Korea has been characterized by an exponential increase in the number of patients receiving surgical treatment. Throughout the last decade, an increasing proportion of surgeries have been performed using minimally invasive methods, with a notable increase in robot-assisted surgery.

The evaluation and management strategies of urologic cancer in Korea are primarily based on an existing evidence-based framework provided by international guidelines. The adoption and clinical application of novel surgical techniques and systemic agents targeted at advanced stage cancer are promptly adopted; accordingly, multidisciplinary treatment options are often available for various cancers at different stages. At the same time, treatment decisions are greatly influenced by the availability of healthcare resources, which may be limited due to the National Health Insurance reimbursement policy.

A racial disparity in cancer features appears to exist for certain urologic cancers among Korean patients, and the optimal management strategy specific for the Korean population has yet to be confirmed. A national comprehensive cancer database is needed for better insight into risk factors, selection of sequential strategies, tumor biology and survival outcome of Korean urologic cancer patients.
DOI
10.1093/jjco/hyv096
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Urology (비뇨의학교실) > 1. Journal Papers
Yonsei Authors
Koo, Kyo Chul(구교철) ORCID logo https://orcid.org/0000-0001-7303-6256
Lee, Kwang Suk(이광석) ORCID logo https://orcid.org/0000-0002-7961-8393
Chung, Byung Ha(정병하) ORCID logo https://orcid.org/0000-0001-9817-3660
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/156927
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links